contact@ronoma-pharma.com
What are you looking for?
RonomaRonoma
  • About Us
  • Alzheimer
  • Ronoma Project
  • Publications
  • FAQ
  • Contact
  • English
    • Français

Blog

HomeRonoma –  Blog

Economy in Normandy 4 Start UP that we will have to follow in 2024

https://www.paris-normandie.fr/id481697/article/2024-01-08/economie-en-normandie-quatre-start-quil-va-falloir-suivre-en-2024

Donecopride, a Swiss army knife with potential against Alzheimer’s disease

https://pubmed.ncbi.nlm.nih.gov/31881553/

Development of Novel Potential Pleiotropic Compounds of Interest in Alzheimer’s Disease Treatment through Rigidification Strategy

https://pubmed.ncbi.nlm.nih.gov/33926141/

Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer’s disease treatment

https://pubmed.ncbi.nlm.nih.gov/31881553/

Novel multitarget-directed ligands (MTDLs) with acetylcholinesterase (AChE) inhibitory and serotonergic subtype 4 receptor (5-HT4R) agonist activities as potential agents against Alzheimer’s disease: the design of donecopride

https://pubmed.ncbi.nlm.nih.gov/25793650/

Categories

  • Press
  • Publications

Recent post

  • Economy in Normandy 4 Start UP that we will have to follow in 2024
  • Donecopride, a Swiss army knife with potential against Alzheimer’s disease

Biotechnology company
Born from Norman research innovation, RonomA is a biotechnology company dedicated to the development and commercialization of an innovative therapy intended for neurodegenerative diseases.

Links

  • Privacy Policy
  • Legal Notice
  • Contact

Posts

  • 20 February 2024Economy in Normandy 4 Start UP that we will have to follow in 2024
  • 19 February 2024Donecopride, a Swiss army knife with potential against Alzheimer’s disease
Copyright Ronoma © 2025 by Dopamine 360. All rights reserved.